Aveni Foundation is committed to expediting the development of gene-targeted therapies for metastatic cancers and other unmet medical needs.

Metastatic cancer is associated with an invariably fatal outcome accounting for 9.6 million deaths worldwide in 2018, a global burden which is expected to increase beyond 16 million by 2040 (World Health Organization, 2019; American Cancer Society, 2019). It is our mission to support the timely development of innovative targeted therapies for cancers and other diseases.

For our first program investment, Aveni Foundation is raising $10M for specific projects that aim to develop promising new therapies which provide clinical benefits without the toxic side effects of chemotherapy.

The foundation is named in honor of Fr. Joseph Aveni, RCJ, a Rogationist priest who experienced significant clinical benefit from a gene-targeted therapy (Intl J Oncol 36:1341-1353, 2010), and whose cause of canonization is ongoing.



2811 Wilshire Blvd #777
Santa Monica, CA 90403






FUNDRAISER: James B. Finn Memorial | November 18, 2019

“All proceeds will be donated to the Aveni Foundation in Jim Finn’s memory. Sponsorships ensure that the Aveni Foundation receives essential funding to provide research development of gene-targeted therapies to the thousands of lives that are touched by metastatic cancers and sarcoma.”